Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Degenerative Intellectual & Developmental Disabilities

Is Tauism Dead?

  • Open or Close Michael AB Naafs*

    Naafs International Health Consultancy, Netherlands

    *Corresponding author: Michael AB Naafs, Naafs International Health Consultancy, Netherlands

Submission: July 02, 2018;Published: July 06, 2018

Volume1 Issue4
July 2018

Abstract

After the latest failure of drug trials in Alzheimer’s disease [1], we have to conclude that we don’t understand the disease [2]. In an editorial in the New England Journal of Medicine, Murphy [3] wrote” the field is clearly in need of innovative ideas and we are very well be nearing the end of the amyloid hypothesis rope”. Antidiabetic drugs will not be the new cure for Alzheimer’s as this research also relies heavily on the amyloid-beta-tau hypothesis [4]. So, is this the end of “Tauism” after 15 years of failing drug trials? Frankly, the answer is yes. Research in neurodegenerative diseases will move more to genetics, epigenetics, immunology and inflammation, as is illustrated by two very recent publications.

Get access to the full text of this article


About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 555 Madison Avenue, 5th floor
  •     New York, NY 10022, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137
  • info@crimsonpublishers.com
  • www.crimsonpublishers.com